88 related articles for article (PubMed ID: 17695514)
1. Distribution of radioiodinated estramustine binding protein antibody in mice with DU-145 prostate cancer xenograft.
Ståhlberg K; Kairemo K; Karonen SL; Taari K; Rannikko S
Anticancer Res; 2007; 27(4B):2275-8. PubMed ID: 17695514
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated estramustine phosphate and estramustine binding protein antibody accumulate in the prostate of a mouse.
Ståhlberg K; Kairemo K; Karonen SL; Jekunen A; Taari K; Rannikko S
Prostate; 1997 Jun; 32(1):1-8. PubMed ID: 9207951
[TBL] [Abstract][Full Text] [Related]
3. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
4. Estramustine-binding protein (EMBP) in renal cell carcinoma immunohistochemistry, immunoscintigraphy and in vitro estramustine effects.
Edgren M; Westlin JE; Letocha H; Nordgren H; Kälkner KM; Nilsson S
Acta Oncol; 1996; 35(4):483-8. PubMed ID: 8695166
[TBL] [Abstract][Full Text] [Related]
5. Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody.
Carter T; Sterling-Levis K; Ow K; Doughty L; Hattarki M; Shapira D; Hewish D; Kortt AA; Russell PJ
Cancer Immunol Immunother; 2004 Jun; 53(6):533-42. PubMed ID: 14722669
[TBL] [Abstract][Full Text] [Related]
6. Purification of estramustine-binding protein and production of monoclonal antibodies to its different components.
Björk P; Donn F; Glad C; Sundblad G; Vestberg M; Kalland T
Prostate; 1995 Aug; 27(2):70-83. PubMed ID: 7638085
[TBL] [Abstract][Full Text] [Related]
7. [Study on biodistribution and imaging of radioiodinated antisense oligonucleotides in nude mice bearing human lymphoma].
Shen J; Wang RF; Zhang CL; Liu M; Guo FQ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):655-9. PubMed ID: 15605104
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
Andratschke M; Gildehaus FJ; Johannson V; Schmitt B; Mack B; Reisbach G; Lang S; Lindhofer H; Zeidler R; Wollenberg B; Luebbers CW
Anticancer Res; 2007; 27(1A):431-6. PubMed ID: 17352264
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
10. The expression of estramustine-binding protein in the human prostatic cancer cell line DU 145 is not androgen dependent.
Eklöv S; Larson A; Björk P; Nilsson S
Scand J Urol Nephrol; 1992; 26(2):119-25. PubMed ID: 1626200
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
Pavlinkova G; Booth BJ; Batra SK; Colcher D
Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
[TBL] [Abstract][Full Text] [Related]
12. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH
Prostate; 1989; 14(1):27-43. PubMed ID: 2648345
[TBL] [Abstract][Full Text] [Related]
13. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
Williams JA; Wessels BW; Edwards JA; Kopher KA; Wanek PM; Wharam MD; Order SE; Klein JL
Cancer Res; 1990 Feb; 50(3 Suppl):974s-979s. PubMed ID: 2404587
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunodetection of prostatic cancer with 125I-labelled antibody against prostatic specific antigen.
Larson A; Arnberg H; Maripuu E; Nilsson S
Scand J Urol Nephrol Suppl; 1988; 110():149-53. PubMed ID: 2460917
[TBL] [Abstract][Full Text] [Related]
15. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
16. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
Shiina H; Sumi H; Ishibe T; Usui T
Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Parry R; Schneider D; Hudson D; Parkes D; Xuan JA; Newton A; Toy P; Lin R; Harkins R; Alicke B; Biroc S; Kretschmer PJ; Halks-Miller M; Klocker H; Zhu Y; Larsen B; Cobb RR; Bringmann P; Roth G; Lewis JS; Dinter H; Parry G
Cancer Res; 2005 Sep; 65(18):8397-405. PubMed ID: 16166318
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
[TBL] [Abstract][Full Text] [Related]
19. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
Björk P; Isaacs JT; Hartley-Asp B
Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
[TBL] [Abstract][Full Text] [Related]
20. Targeting tomoregulin for radioimmunotherapy of prostate cancer.
Zhao XY; Schneider D; Biroc SL; Parry R; Alicke B; Toy P; Xuan JA; Sakamoto C; Wada K; Schulze M; Müller-Tiemann B; Parry G; Dinter H
Cancer Res; 2005 Apr; 65(7):2846-53. PubMed ID: 15805286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
